Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

Go back to Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
(NASDAQ: ALLO) Delayed: 1.65 -0.02 (1.2%)
Previous Close $1.67    52 Week High $ 
Open $1.69    52 Week Low $ 
Day High $1.70    P/E N/A 
Day Low $1.63    EPS $ 
Volume 3,621,657